ResMed (ASX:RMD) Chief Executive Michael Farrell sold 8,009 of his shares in the company on the New York Stock Exchange, with an aggregate market value of about $2.2 million, according to a Tuesday filing with the Australian bourse.
Following the transaction, Farrell owns nearly 146.4 million shares and other units outstanding in the company, per the filing.